Return to Article Details Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II Download Download PDF
Themes by Openjournaltheme.com Themes by Openjournaltheme.com